by The global lymphedema treatment market consists of treatment devices and drugs used for treatment of lymphedema. Lymphedema is a medical condition caused by a blockage in the lymphatic system which leads to swelling in arms, legs or any other body parts. It is commonly caused by cancer treatment like radiation therapy and surgery which damages lymphatic vessels. The rising cases of lymphedema due to growing cancer patient population is driving the demand for lymphedema treatment globally. Treatment devices like compression pumps, compression garments and bandages are used to manage symptoms and prevent worsening of lymphedema. Drugs like diuretics are also prescribed to reduce swelling.
The global lymphedema treatment market is estimated to be valued at US$ 2.29 Bn in 2024 and is expected to exhibit a CAGR of 21% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends
One of the key trends in the global lymphedema treatment market is the rising popularity of advanced compression devices. Manufacturers are focusing on development of compression devices integrated with new technologies like Bluetooth and apps for remote monitoring. This allows patients to self-manage lymphedema at home and seek help remotely in case of issues. Another trend is the growing adoption of Complex Decongestive Therapy (CDT) which is a non-invasive gold standard treatment combining manual lymph drainage, bandaging, compression therapy and skin care. Its effectiveness is boosting its utilization for lymphedema management globally. There is also a rising adoption of laser and light therapies as adjunct treatments for lymphedema. Low-level light therapy and near-infrared light therapy are showing promise in reducing swelling and improving lymphatic drainage without any side effects.
Porter’s Analysis
Threat of new entrants: Low capital requirements allow for potential new entrants in lymphedema treatment. However, established brands have significant funding for R&D and production capabilities.
Bargaining power of buyers: Large drug retailers and private label brands have significant influence over pricing and product selection for lymphedema treatment options.
Bargaining power of suppliers: Key raw material suppliers for lymphedema treatment products have some pricing influence, though intellectual property provides brand protection.
Threat of new substitutes: Alternative therapies and self-treatment options pose a medium threat, though prescription products have clinical legitimacy.
Competitive rivalry: Major lymphedema treatment brands compete on R&D, branding, and customer experience to gain market share.
Key Takeaways
Global Lymphedema Treatment Market Size is expected to witness high growth over the forecast period of 2024 to 2031.
Regional analysis: North America holds the highest market share currently dominated by the US and Canada. This is attributed to presence of major lymphedema treatment brands, rising awareness about condition management, and supportive insurance policies in the region. Asia Pacific is expected to grow at fastest pace owing to increasing healthcare expenditure and expanding medical tourism in countries like India and China.
Key players: Key players operating in the lymphedema treatment market are Walmart Inc., Under Armour, Inc., Givex Corporation, American Express, Target Brands, Inc., Best Buy, Starbucks Coffee Company, PayPal Holdings, Inc., Apple Inc., Sephora USA, Inc., Gyft, Inc., Walgreen Co., TransGate Solutions, AMILON S.R.L., Jigsaw Business Solutions, Diggecard, Pine Labs Private Limited, Alltimeprint.com, Plastek Card Solutions, Inc., Card USA, Inc., Duracard, Blackhawk Network, Tango Card. Inc, Stockpile, Inc., and Huuray A/S among others.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
